Gene · 54894
Papers2,200
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,200
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Conversational AI agent for precision oncology: AI-HOPE-WNT integrates clinical and genomic data to investigate WNT pathway dysregulation in colorectal cancer. | Front Artif Intell | 2025 | 40860720 | PubTator, text mining | PubMed |
| Assessing genotype-phenotype correlations in colorectal cancer with deep learning: a multicentre cohort study. | Lancet Digit Health | 2025 | 40829965 | PubTator, text mining | PubMed |
| Facile expression of proteins with desired N-terminal amino acid via an engineered cysteine protease domain. | Commun Biol | 2025 | 40770049 | PubTator, text mining | PubMed |
| Membrane Contact Sites in Proteostasis and ER Stress Response. | Contact (Thousand Oaks) | 2025 | 40735229 | PubTator, text mining | PubMed |
| Enhanced response to dabrafenib plus trametinib in a patient with BRAF V600E lung cancer harboring an RNF43 variant of unknown significance: a case report. | Front Oncol | 2025 | 40735046 | PubTator, text mining | PubMed |
| BRAFV600E augments WNT signaling in colorectal cancer via aberrant DNA methylation. | iScience | 2025 | 40687798 | PubTator, text mining | PubMed |
| Diagnostic accuracy and risk stratification of pancreatic cyst fluids diagnosed as mucinous neoplasms without mucinous epithelium. | Cancer Cytopathol | 2025 | 40637392 | PubTator, text mining | PubMed |
| Tumoral RCOR2 promotes tumor development through dual epigenetic regulation of tumor plasticity and immunogenicity. | J Clin Invest | 2025 | 40608411 | PubTator, text mining | PubMed |
| Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial. | Anticancer Res | 2025 | 40578933 | PubTator, text mining | PubMed |
| Emerging Concepts of Targeted Protein Degrader Technologies via Lysosomal Pathways. | Int J Mol Sci | 2025 | 40565046 | PubTator, text mining | PubMed |
| Recent advances in pediatric colorectal cancer: a systematic review. | Pediatr Surg Int | 2025 | 40531222 | PubTator, text mining | PubMed |
| LncRNA MIR503HG regulates NETs-mediated NLRP3 inflammasome activation and NSCLC metastasis by enhancing the ubiquitination of C/EBPβ. | Clin Transl Med | 2025 | 40490947 | PubTator, text mining | PubMed |
| Frizzled receptors: gatekeepers of Wnt signaling in development and disease. | Front Cell Dev Biol | 2025 | 40376615 | PubTator, text mining | PubMed |
| Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization. | J Pathol | 2025 | 40371932 | PubTator, text mining | PubMed |
| Myelodysplastic syndrome diagnosed by genetic testing for hereditary cancer: a case report. | NPJ Genom Med | 2025 | 40368914 | PubTator, text mining | PubMed |
| Chemotherapy-induced macrophage CXCL7 expression drives tumor chemoresistance via the STAT1/PHGDH-serine metabolism axis and SAM paracrine feedback to M2 polarization. | Cell Death Dis | 2025 | 40368902 | PubTator, text mining | PubMed |
| Molecular Heterogeneity in Early-Onset Colorectal Cancer: Pathway-Specific Insights in High-Risk Populations. | Cancers (Basel) | 2025 | 40282501 | PubTator, text mining | PubMed |
| The impact of an RNA-binding protein group on regulating the RSPO-LGR4/5-ZNRF3/RNF43 module and the immune microenvironment in hepatocellular carcinoma. | BMC Cancer | 2025 | 40264052 | PubTator, text mining | PubMed |
| Qingre Huayu Jianpi decoction suppresses colorectal tumorigenesis by inhibiting cancer stem cells and cancer-associated fibroblasts. | J Ethnopharmacol | 2025 | 40220938 | PubTator, text mining | PubMed |
| Whole genome sequencing of 378 prostate cancer metastases reveals tissue selectivity for mismatch deficiency with potential therapeutic implications. | Genome Med | 2025 | 40114169 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54894/papers?page=5